Diabetic retinopathy, caused by high blood sugar, is a leading cause of vision loss globally, affecting millions including 65 ...

Disc neovascularization (NVD) was less frequent among patients with proliferative diabetic retinopathy but was associated with more resistance to currently available treatments compared with ...

STOCKHOLM — At the American Society of Retina Specialists (ASRS) 2024 Annual Meeting, researchers discussed how insights into potential risk factors and new treatments could improve outcomes for ...

A single injection of sura-vec reduced the severity of nonproliferative diabetic retinopathy for up to 2 years, according to ...

For patients with type 2 diabetes mellitus, most eyes have no worsening of diabetic retinopathy (DR) after initiation of semaglutide, according to a study presented at the annual meeting of the ...

Please provide your email address to receive an email when new articles are posted on . INDIANAPOLIS — APX3330, an investigational oral treatment for diabetic retinopathy, reduced the development of ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. This piece also marks part ...

Share on Pinterest A study finds 1 in 4 people with diabetes have diabetic retinopathy. Azman Jaka/Getty Images A new study finds a quarter of people with diabetes have retinopathy. Diabetic ...

REGENXBIO Inc. (Nasdaq: RGNX) today announced the first patient has been dosed in the Phase IIb/III NAAVIGATE clinical trial of investigational surabgene lomparvovec (sura-vec, ABBV-RGX-314) in ...